A detailed history of Field & Main Bank transactions in Baxter International Inc stock. As of the latest transaction made, Field & Main Bank holds 1,000 shares of BAX stock, worth $33,210. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$33,210
Previous $33,000 12.12%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$32.87 - $43.55 $9,861 - $13,065
-300 Reduced 23.08%
1,000 $33,000
Q2 2023

Jul 26, 2023

SELL
$39.98 - $47.68 $50,974 - $60,792
-1,275 Reduced 49.51%
1,300 $59,000
Q4 2022

Jan 19, 2023

SELL
$49.7 - $57.71 $33,547 - $38,954
-675 Reduced 20.77%
2,575 $0
Q3 2022

Oct 25, 2022

SELL
$53.86 - $66.8 $26,930 - $33,400
-500 Reduced 13.33%
3,250 $175,000
Q2 2022

Jul 18, 2022

BUY
$63.83 - $80.0 $25,532 - $32,000
400 Added 11.94%
3,750 $241,000
Q1 2022

Apr 21, 2022

SELL
$76.85 - $89.45 $24,592 - $28,624
-320 Reduced 8.72%
3,350 $260,000
Q3 2021

Oct 14, 2021

SELL
$73.77 - $83.61 $29,876 - $33,862
-405 Reduced 9.94%
3,670 $295,000
Q2 2021

Jul 15, 2021

BUY
$80.5 - $88.01 $32,200 - $35,204
400 Added 10.88%
4,075 $328,000
Q1 2021

Apr 30, 2021

BUY
$76.38 - $86.03 $11,457 - $12,904
150 Added 4.26%
3,675 $310,000
Q4 2020

Feb 25, 2021

BUY
$75.39 - $82.36 $11,308 - $12,354
150 Added 4.44%
3,525 $283,000
Q3 2020

Oct 22, 2020

SELL
$78.33 - $90.73 $1,958 - $2,268
-25 Reduced 0.74%
3,375 $271,000
Q2 2020

Aug 12, 2020

SELL
$78.66 - $94.14 $31,464 - $37,656
-400 Reduced 10.53%
3,400 $293,000
Q1 2019

Apr 24, 2019

SELL
$64.48 - $81.31 $19,344 - $24,393
-300 Reduced 7.32%
3,800 $309,000
Q4 2017

Jan 24, 2018

BUY
$61.45 - $66.05 $251,945 - $270,805
4,100
4,100 $265,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Field & Main Bank Portfolio

Follow Field & Main Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.